Sarepta Therapeutics (NasdaqGS:SRPT) Update / briefing March 25, 2026 08:30 AM ET Company ParticipantsAndrew Tsai - Managing DirectorBrian Abrahams - Head of Biotechnology ResearchDoug Ingram - CEOGavin Clark-Gartner - Managing DirectorJames Richardson - Chief Medical OfficerJoshua Fleischman - Biotech Equity Research AssociateKostas Biliouris - Managing Director of Biotech ResearchKuan-Hung Lin - Biotechnology Equity Research AssociateLouise Rodino-Klapac - President of R&D and Technical OperationsMike Ulz ...